AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
46.68
+0.47 (1.02%)
At close: Jan 21, 2026, 4:00 PM EST
46.05
-0.63 (-1.35%)
After-hours: Jan 21, 2026, 6:42 PM EST

AnaptysBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,292403569881961588
Upgrade
Market Cap Growth
190.91%-29.23%-35.39%-8.28%63.38%33.35%
Upgrade
Enterprise Value
1,367340486760608251
Upgrade
Last Close Price
46.2113.2421.4230.9934.7521.50
Upgrade
Forward PE
----16.86-
Upgrade
PS Ratio
8.024.4133.1885.6515.217.84
Upgrade
PB Ratio
-5.696.463.362.701.48
Upgrade
P/TBV Ratio
-5.696.463.362.701.48
Upgrade
EV/Sales Ratio
8.073.7228.3173.849.623.34
Upgrade
Debt / Equity Ratio
-11.785.213.731.240.760.00
Upgrade
Asset Turnover
0.400.200.030.020.120.18
Upgrade
Quick Ratio
8.529.3810.6216.9934.1019.86
Upgrade
Current Ratio
8.689.5110.8717.1734.4020.01
Upgrade
Return on Equity (ROE)
-308.02%-182.71%-93.44%-41.62%-15.35%-4.97%
Upgrade
Return on Assets (ROA)
-4.23%-15.35%-18.47%-11.48%-6.70%-3.50%
Upgrade
Return on Capital Employed (ROCE)
-9.10%-26.20%-37.90%-19.70%-9.10%-6.00%
Upgrade
Earnings Yield
-6.67%-36.05%-28.74%-14.61%-6.02%-3.39%
Upgrade
FCF Yield
-11.45%-33.68%-21.36%-8.39%-4.92%-2.50%
Upgrade
Buyback Yield / Dilution
-7.36%-5.42%4.41%-2.68%-0.47%-0.90%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q